|
|||||
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. . . . → Read More: DNA-Encoded Synthetic Antibodies Protect Against Ebola 
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines 
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round 
Two institutions in Massachusetts are starting a program to help inventors and new enterprises anywhere in the U.S. bring their point-of-care medical devices to market. . . . → Read More: NIH Funds Support for Point-of-Care Device Entrepreneurs 
Harvard Medical School is the recipient of a gift from the Blavatnik Family Foundation to develop innovative treatments, apply advanced digital technologies, and accelerate biotech and life science start-up companies. . . . → Read More: $200M Gift Supporting Translational Research, Start-Up Incubator 
A current drug for leukemia, with a simple protein chemically added, is shown in tests with lab mice to accelerate the healing of broken bones. . . . → Read More: Modified Cancer Drug Hastens Bone Fracture Healing 
Proteins known to regulate immune cells, given as nanoscale particles, are shown in lab mice to encourage long-term acceptance of a transplanted heart. . . . → Read More: Nanotech Immunotherapy Reduces Heart Transplant Rejection 
Researchers in chemistry at two institutions report new techniques that lab tests show modify current antibiotics to make them more effective against infections that resist today’s antibiotics. . . . → Read More: New Processes Devised to Boost Antibiotics 
An engineering lab at MIT and the R&D hub at Munich, Germany’s international airport are studying the use of digital technologies to improve urban life, using the hub’s campus as a laboratory. . . . → Read More: Munich Airport, MIT Lab Partner on Smart City 
Developers of a system that uses high-speed genomic analysis with standard semiconductor chips say they demonstrated an ability to sequence bacterial DNA directly from raw blood samples. . . . → Read More: Rapid Antimicrobial Resistance Diagnostics System Advances |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
